Evaluation of Patients with Neural Tube Defect in A Tertiary Clinic

Objective & Hypothesis:Objective: We aimed to evaluate the maternal risk factors and postnatal clinical status of fetuses with neural tube defects in our tertiary clinic.

📊

Key Findings & Data:Objective: We aimed to evaluate the maternal risk factors and postnatal clinical status of fetuses with neural tube defects in our tertiary clinic.

💡

Conclusion & Impact:Objective: We aimed to evaluate the maternal risk factors and postnatal clinical status of fetuses with neural tube defects in our tertiary clinic.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:gebelik · nöral tüp defekti · nöral tüp defekti risk faktörleri

Abstract

Objective: We aimed to evaluate the maternal risk factors and postnatal clinical status of fetuses with neural tube defects in our tertiary clinic.

Özet

Amaç: Üçüncü düzey kliniğimizdeki nöral tüp defektli fetüslerin maternal risk faktörlerini ve postnatal kliniklerini değerlendirmeyi amaçladık.

Keywords

gebelik nöral tüp defekti nöral tüp defekti risk faktörleri Pregnancy neural tube defect neural tube defect risk factors

🔖

Cite This Article

YENİÇERİ, H., IŞIKALAN, M. M., ACAR, A. (2021). Evaluation of Patients with Neural Tube Defect in A Tertiary Clinic. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 23 - Sayı: 1, 68–74. https://ajindex.com/articles/398092

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (12)

Sawin KJ, Liu T, Ward E, Thibadeau J, Schechter MS, Soe MM et al. The national spina bifida patient registry: profile of a large cohort of participants from the first 10 clinics. J Pediatr. 2015;166(2):444-50.e1
Wang Y, Liu G, Canfield MA, Mai CT, Gilboa SM, Meyer RE et al. Racial/ethnic differences in survival of United States children with birth defects: a population-based study. J Pediatr. 2015;166(4):819-26.e1-2
Kinsner-Ovaskainen A, Lanzoni M, Garne E, Loane M, Morris J, Neville A et al. A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration. Eur J Med Genet. 2018;61(9):513-7
McLone DG. The etiology of neural tube defects: the role of folic acid. Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery. 2003;19(7-8):537-9
Ghi T, Pilu G, Falco P, Segata M, Carletti A, Cocchi G et al. Prenatal diagnosis of open and closed spina bifida. Ultrasound in Obstetrics Gynecology. 2006;28(7):899-903
Deak KL, Siegel DG, George TM, Gregory S, Ashley-Koch A, Speer MC. Further evidence for a maternal genetic effect and a sex-influenced effect contributing to risk for human neural tube defects. Birth Defects Res A Clin Mol Teratol. 2008;82(10):662-9
Yin Z, Xu W, Xu C, Zhang S, Zheng Y, Wang W et al. A population-based case-control study of risk factors for neural tube defects in Shenyang, China. Childs Nerv Syst. 2011;27(1):149-54
Meng X, Sun Y, Duan W, Jia C. Meta-analysis of the association of maternal smoking and passive smoking during pregnancy with neural tube defects. Int J Gynaecol Obstet. 2018;140(1):18-25
Suarez L, Ramadhani T, Felkner M, Canfield MA, Brender JD, Romitti PA et al. Maternal smoking, passive tobacco smoke, and neural tube defects. Birth Defects Res A Clin Mol Teratol. 2011;91(1):29-33
Wang M, Wang ZP, Zhang M, Zhao ZT. Maternal passive smoking during pregnancy and neural tube defects in offspring: a meta-analysis. Arch Gynecol Obstet. 2014;289(3):513-21
Li ZW, Liu JM, Ren AG, Zhang L, Guo ZY, Li Z. Maternal passive smoking and the risk of neural tube defects: a case-control study in Shanxi province, China. Zhonghua Liu Xing Bing Xue Za Zhi. 2008;29(5):417-20
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FA et al. Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services